{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:35Z","timestamp":1792783115563,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Ministry","award":["2017ZX09101001"],"award-info":[{"award-number":["2017ZX09101001"]}]},{"name":"Gansu Science and Technology Fund Grant","award":["17ZD2FA009 and 18JR3RA417"],"award-info":[{"award-number":["17ZD2FA009 and 18JR3RA417"]}]},{"name":"Lanzhou Science and Technology Bureau Program Funds","award":["2021-1-141, 2021-RC-86"],"award-info":[{"award-number":["2021-1-141, 2021-RC-86"]}],"id":[{"id":"https:\/\/ror.org\/030q46522","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11515-4","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:54:20Z","timestamp":1773831260000},"page":"7265-7284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis and anti-liver fibrotic activity study of a chalcone derivative through anti-inflammatory effects and inhibition of JNK\/NF-\u03baB signaling pathways"],"prefix":"10.1007","volume":"30","author":[{"given":"Chunwei","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"11515_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.etap.2019.03.008","volume":"68","author":"ZB Zhao","year":"2019","unstructured":"Zhao ZB, Ji K, Shen XY, Zhang WW, Wang R, Xu WP, Wei W (2019) Di(2-ethylhexyl) phthalate promotes hepatic fibrosis by regulation of oxidative stress and inflammation responses in rats. Environ Toxicol Phar 68:109\u2013119","journal-title":"Environ Toxicol Phar"},{"key":"11515_CR2","doi-asserted-by":"publisher","first-page":"56267","DOI":"10.18632\/oncotarget.17453","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, Dong XY, Wang LL, Shan LL, Li T, Xu WF, Ding Y, Lai MQ, Lin XJ, Dai M, Bai XC, Jia CH, Zheng H (2017) Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-beta\/Smad signaling pathway. Oncotarget 8:56267\u201356280","journal-title":"Oncotarget"},{"key":"11515_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","volume":"8","author":"T Luedde","year":"2011","unstructured":"Luedde T, Schwabe RF (2011) NF-kappaB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8:108\u2013118","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11515_CR4","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver (2014) EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol 61:183\u2013184","DOI":"10.1016\/j.jhep.2014.03.002"},{"key":"11515_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/hep.22820","volume":"49","author":"NKM Van Hul","year":"2009","unstructured":"Van Hul NKM, Abarca-Quinones J, Sempoux C, Horsmans Y, Leclercq IA (2009) Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 49:1625\u20131635","journal-title":"Hepatology"},{"key":"11515_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.28948","volume":"65","author":"T Kisseleva","year":"2017","unstructured":"Kisseleva T (2017) The origin of fibrogenic myofibroblasts in fibrotic liver. Hepatology 65:1039\u20131043","journal-title":"Hepatology"},{"key":"11515_CR7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1582-4934.2007.00092.x","volume":"11","author":"OA Gressner","year":"2007","unstructured":"Gressner OA, Weiskirchen R, Gressner AM (2007) Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med 11:1031\u20131051","journal-title":"J Cell Mol Med"},{"key":"11515_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastro Hepat 18:151\u2013166","journal-title":"Nat Rev Gastro Hepat"},{"key":"11515_CR9","doi-asserted-by":"publisher","first-page":"e1499","DOI":"10.1002\/wsbm.1499","volume":"13","author":"J Berumen","year":"2021","unstructured":"Berumen J, Baglieri J, Kisseleva T, Mekeel K (2021) Liver fibrosis: pathophysiology and clinical implications. WIREs Mech Disease 13:e1499","journal-title":"WIREs Mech Disease"},{"key":"11515_CR10","doi-asserted-by":"publisher","first-page":"106766","DOI":"10.1016\/j.phrs.2023.106766","volume":"191","author":"P Xing","year":"2023","unstructured":"Xing P et al (2023) Natural products in digestive tract tumors metabolism: functional and application prospects. Pharmacol Res 191:106766","journal-title":"Pharmacol Res"},{"key":"11515_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.pharep.2016.03.004","volume":"68","author":"L Karkhaneh","year":"2016","unstructured":"Karkhaneh L, Yaghmaei P, Parivar K, Sadeghizadeh M, Ebrahim-Habibi A (2016) Effect of trans-chalcone on atheroma plaque formation, liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice. Pharmacol Rep 68:720\u2013727","journal-title":"Pharmacol Rep"},{"key":"11515_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12263-011-0210-5","volume":"6","author":"B Orlikova","year":"2011","unstructured":"Orlikova B, Tasdemir D, Golais F, Dicato M, Diederich M (2011) Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes Nutr 6:125\u2013147","journal-title":"Genes Nutr"},{"key":"11515_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2017.11.022","volume":"129","author":"E Karimi-Sales","year":"2018","unstructured":"Karimi-Sales E, Mohaddes G, Alipour MR (2018) Chalcones as putative hepatoprotective agents: preclinical evidence and molecular mechanisms. Pharmacol Res 129:177\u2013187","journal-title":"Pharmacol Res"},{"key":"11515_CR14","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1021\/jm2002348","volume":"54","author":"V Kumar","year":"2011","unstructured":"Kumar V, Kumar S, Hassan M, Wu HL, Thimmulappa RK, Kumar A, Sharma SK, Parmar VS, Biswal S, Malhotra SV (2011)Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells. J Med Chem 54:4147\u20134159","journal-title":"J Med Chem"},{"key":"11515_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1248\/bpb.30.145","volume":"30","author":"Y Sato","year":"2007","unstructured":"Sato Y, He J-X, Nagai H, Tani T, Akao T (2007) Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza Ularensis Roots, acts in the lower part of intestine. Biol Pharm Bull 30:145\u2013149","journal-title":"Biol Pharm Bull"},{"key":"11515_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","volume":"42","author":"Z Nowakowska","year":"2007","unstructured":"Nowakowska Z (2007) A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 42:125\u2013137","journal-title":"Eur J Med Chem"},{"issue":"8","key":"11515_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1139\/cjpp-2016-0071","volume":"94","author":"H Singh","year":"2016","unstructured":"Singh H, Sidhu S, Chopra K et al (2016) Hepatoprotective effect of trans-Chalcone on experimentally induced hepatic injury in rats: inhibition of hepatic inflammation and fibrosis[J]. Can J Physiol Pharmacol 94(8):879\u2013887","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"11515_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jcma.2014.01.007","volume":"77","author":"AR Zuo","year":"2014","unstructured":"Zuo AR, Yu YY, Shu QL et al (2014) Hepatoprotective effects and antioxidant, antityrosinase activities of phloretin and phloretin isonicotinyl hydrazone[J]. J Chin Med Association 77(6):290\u2013301","journal-title":"J Chin Med Association"},{"key":"11515_CR19","doi-asserted-by":"crossref","unstructured":"Yu WG, Jie Q, Lu YH (2011) Hepatoprotective effects of 2\u2019,4\u2019-dihydroxy-6\u2019-methoxy-3\u2019,5\u2019- dime-thylchalcone on CCl4-induced acute liver injury in mice. J Agri Food Chem 59(24):12821\u201312829","DOI":"10.1021\/jf2042032"},{"key":"11515_CR20","unstructured":"Reza A, Natanzi E, Mahmoudian S et al (2011) Hepatoprotective activity of phloretin and hydroxychalcones against Acetaminophen Induced hepatotoxicity in mice. Toxicol Lett 196(Suppl 2):S37\u2013S351"},{"key":"11515_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2017.11.022","volume":"129","author":"E Karimi-Sales","year":"2018","unstructured":"Karimi-Sales E, Mohaddes G, Alipour MR (2018) Chalcones as putative hepatoprotective agents: preclinical evidence and molecular mechanisms. Pharmacol Res 129:177\u2013187","journal-title":"Pharmacol Res"},{"issue":"10","key":"11515_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jbt.21814","volume":"30","author":"TO Ajiboye","year":"2016","unstructured":"Ajiboye TO, Lophirones B (2016) Attenuate acetaminophen-induced liver damage in Mice: studies on Hepatic, Oxidative stress and inflammatory biomarkers. J Biochem Mol Toxicol 30(10):497\u2013505","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"11515_CR23","first-page":"29","volume":"5","author":"C Dorn","year":"2012","unstructured":"Dorn C, Heilmann J, Hellerbrand C (2012) Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis[J]. Int J Clin Exp Pathol 5(1):29\u201336","journal-title":"Int J Clin Exp Pathol"},{"key":"11515_CR24","doi-asserted-by":"crossref","unstructured":"Li Y, Shi Y, Sun Y et al (2017) Restorative effects of hydroxysafflor yellow a on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride. Mol Med Rep 15(1):47\u201356","DOI":"10.3892\/mmr.2016.5965"},{"issue":"1","key":"11515_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbi.2003.10.005","volume":"147","author":"SJ Lee","year":"2004","unstructured":"Lee SJ, Kim YG, Kang KW et al (2004) Effects of colchicine on liver functions of cirrhotic rats: beneficial effects result from stellate cell inactivation and inhibition of TGF \u03b21 expression[J]. Chemico-Biol Interact 147(1):9\u201321","journal-title":"Chemico-Biol Interact"},{"issue":"1","key":"11515_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2011.01.067","volume":"658","author":"SH Lee","year":"2011","unstructured":"Lee SH, Zhao YZ, Park EJ et al (2011) 2 \u2018,4 \u2018,6 \u2018-Tris(methoxymethoxy) chalcone induces apoptosis by enhancing Fas-ligand in activated hepatic stellate cells. Eur J Pharmacol 658(1):9\u201315","journal-title":"Eur J Pharmacol"},{"key":"11515_CR27","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, Pradere JP, Schwabe RF (2013) Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 4:2823","journal-title":"Nat Commun"},{"key":"11515_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/hep.29885","volume":"68","author":"T Lan","year":"2018","unstructured":"Lan T, Li C, Yang G, Sun Y, Zhuang L, Ou Y, Li H, Wang G, Kisseleva T, Brenner D, Guo J (2018) Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2. Hepatology 68:1070\u20131086","journal-title":"Hepatology"},{"key":"11515_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/187152809789352230","volume":"8","author":"F Heymann","year":"2009","unstructured":"Heymann F, Trautwein C, Tacke F (2009)Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy - Drug Targets 8:307\u2013318","journal-title":"Inflamm Allergy - Drug Targets"},{"key":"11515_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/s30800276","volume":"3","author":"J Sun","year":"2003","unstructured":"Sun J, Zhang X, Broderick M, Fein H (2003) Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 3:276\u2013284","journal-title":"Sensors"},{"key":"11515_CR31","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.3748\/wjg.v20.i23.7242","volume":"20","author":"L Giannitrapani","year":"2014","unstructured":"Giannitrapani L, Soresi M, Bondi ML, Montalto G, Cervello M (2014) Nanotechnology applications for the therapy of liver fibrosis. World J Gastroentero 20:7242\u20137251","journal-title":"World J Gastroentero"},{"key":"11515_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7150\/thno.46360","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiang C, Zhong F, Zhang Y, Wang L, Zhao Y, Wang J, Ding C, Jin L, He F, Wang H (2021) Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics 11:361\u2013378","journal-title":"Theranostics"},{"key":"11515_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.yexcr.2017.02.038","volume":"352","author":"Y Huang","year":"2017","unstructured":"Huang Y, Deng X, Liang J (2017) Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res 352:420\u2013426","journal-title":"Exp Cell Res"},{"key":"11515_CR34","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1038\/cddis.2013.2","volume":"4","author":"HL Lanz","year":"2013","unstructured":"Lanz HL, Zimmerman RM, Brouwer J, Noteborn MH, Backendorf C (2013) Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin. Cell Death Dis 4:e487","journal-title":"Cell Death Dis"},{"key":"11515_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/152165400410281","volume":"49","author":"J Sastre","year":"2000","unstructured":"Sastre J, Pallard\u00f3 FV, Vi\u00f1a J (2000) Mitochondrial Oxidative Stress Plays a Key Role in Aging and Apoptosis. IUBMB Life 49:427\u2013435","journal-title":"IUBMB Life"},{"key":"11515_CR36","doi-asserted-by":"crossref","unstructured":"Gross A (2016) BCL-2 family proteins as regulators of mitochondria metabolism. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1857:1243\u20131246","DOI":"10.1016\/j.bbabio.2016.01.017"},{"key":"11515_CR37","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/hep.510290640","volume":"29","author":"K Ikeda","year":"1999","unstructured":"Ikeda K, Wakahara T, Wang YQ, Kadoya H, Kawada N, Kaneda K (1999) In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology 29:1760\u20131767","journal-title":"Hepatology"},{"key":"11515_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/hep.20853","volume":"42","author":"XM Wang","year":"2005","unstructured":"Wang XM, Yu DMT, McCaughan GW, Gorrell MD (2005) Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology 42:935\u2013945","journal-title":"Hepatology"},{"key":"11515_CR39","doi-asserted-by":"publisher","first-page":"115459","DOI":"10.1016\/j.jep.2022.115459","volume":"296","author":"H Zhao","year":"2022","unstructured":"Zhao H, Wu L, Zhang Y, Feng S, Ding Y, Deng X, Feng R, Li J, Ma T, Huang C (2022) Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation. J Ethnopharmacol 296:115459","journal-title":"J Ethnopharmacol"},{"key":"11515_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2015.11.010","volume":"70","author":"T Xu","year":"2016","unstructured":"Xu T, Ni M-m, Xing L, Li X-f, Meng X-m, Huang C, Li J (2016) NLRC5 regulates TGF-\u03b21-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. Int J Biochem Cell Biol 70:92\u2013104","journal-title":"Int J Biochem Cell Biol"},{"key":"11515_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ebiom.2019.01.009","volume":"40","author":"J Li","year":"2019","unstructured":"Li J, Wang Y, Ma M, Jiang S, Zhang X, Zhang Y, Yang X, Xu C, Tian G, Li Q, Wang Y, Zhu L, Nie H, Feng M, Xia Q, Gu J, Xu Q, Zhang Z (2019) Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-\u03b2 signaling. Ebiomedicine 40:43\u201355","journal-title":"Ebiomedicine"},{"key":"11515_CR42","first-page":"217","volume":"5","author":"P Kocabayoglu","year":"2013","unstructured":"Kocabayoglu P, Friedman SL (2013) Cellular basis of hepatic fibrosis and its role in inflammation and cancer. FBS 5:217\u2013230","journal-title":"FBS"},{"key":"11515_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/acs.jafc.6b04805","volume":"65","author":"JH Choi","year":"2017","unstructured":"Choi JH, Jin SW, Choi CY, Kim HG, Lee GH, Kim YA, Chung YC, Jeong HG (2017) Capsaicin inhibits dimethylnitrosamine-induced hepatic fibrosis by inhibiting the TGF-\u03b21\/Smad pathway via peroxisome proliferator-activated receptor gamma activation. J Agr Food Chem 65:317\u2013326","journal-title":"J Agr Food Chem"},{"key":"11515_CR44","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1038\/onc.2008.300","volume":"27","author":"B Sun","year":"2008","unstructured":"Sun B, Karin M (2008) NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene 27:6228\u20136244","journal-title":"Oncogene"},{"issue":"10","key":"11515_CR45","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.cell.2024.03.027","volume":"187","author":"M Takahashi","year":"2024","unstructured":"Takahashi M et al (2024) DrugMap: a quantitative pan-cancer analysis of cysteine ligandability. Cell 187(10):2536\u20132556e30","journal-title":"Cell"},{"issue":"2","key":"11515_CR46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bmcl.2008.11.077","volume":"19","author":"SD Chamberlain","year":"2009","unstructured":"Chamberlain SD et al (2009) Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity. Bioorg Med Chem Lett 19(2):360\u2013364","journal-title":"Bioorg Med Chem Lett"},{"key":"11515_CR47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1248\/bpb.33.983","volume":"33","author":"A Itoh","year":"2010","unstructured":"Itoh A, Isoda K, Kondoh M, Kawase M, Watari A, Kobayashi M, Tamesada M, Yagi K (2010) Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury. Biol Pharm Bull 33:983\u2013987","journal-title":"Biol Pharm Bull"},{"key":"11515_CR48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.fct.2010.12.006","volume":"49","author":"R Domitrovi\u0107","year":"2011","unstructured":"Domitrovi\u0107 R, Jakovac H (2011) Effects of standardized bilberry fruit extract (Mirtoselect\u00ae) on resolution of CCl4-induced liver fibrosis in mice. Food Chem Toxicol 49:848\u2013854","journal-title":"Food Chem Toxicol"},{"key":"11515_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann F, Tacke F (2016) Immunology in the liver\u2014from homeostasis to disease. Nat Rev Gastro Hepat 13:88\u2013110","journal-title":"Nat Rev Gastro Hepat"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11515-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:03:34Z","timestamp":1791165814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11515-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11515"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11515-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8102523\/v1","asserted-by":"object"}]},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Coonflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}